Help | RSS Feed

Albany Molecular Research (NASD:AMRI) Seasonal Chart

Albany Molecular Research (NASD:AMRI) Seasonality

AMRI Relative to the S&P 500
AMRI Relative to the S&P 500

AMRI Relative to the Sector
AMRI Relative to the Sector

Monthly Seasonal Albany Molecular Research (NASD:AMRI)

Seasonal Chart Analysis

Analysis of the Albany Molecular Research (NASD:AMRI) seasonal charts above shows that a Buy Date of April 26 and a Sell Date of August 4 has resulted in a geometric average return of 6.18% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 9.01% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Albany Molecular Research Inc is a contract research and manufacturing company, providing customers drug discovery, development and manufacturing services.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore